Durga Prasanna Misra
Overview
Explore the profile of Durga Prasanna Misra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
1659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Qamar T, Misra D, Kar S
Life Sci
. 2024 Nov;
361:123281.
PMID: 39608445
Semaphorins have been discovered to play an array of roles in immune regulation, especially in the complex field of inflammatory and autoimmune disorders. Originally discovered for their critical role in...
2.
Thakare D, Singh K, Qamar T, Singh D, Balakrishnan S, Rathore U, et al.
J Inflamm Res
. 2024 Nov;
17:8695-8712.
PMID: 39553310
Purpose: Existing biomarkers including C-reactive protein (CRP) do not adequately distinguish active and inactive TAK. We compared serum p-glycoprotein (p-gp)/Multidrug Resistance Protein 1 (MDR1), monomeric CRP (mCRP), CRP, and mCRP:CRP...
3.
Misra D
Best Pract Res Clin Rheumatol
. 2024 Nov;
39(1):102020.
PMID: 39489658
Symmetric inflammatory polyarthritis is the most prominent manifestation of rheumatoid arthritis (RA). However, RA can practically affect any organ system, whether hematologic, neurological, cardiac, lung, skin, eyes, or kidneys. Systemic...
4.
Dhooria A, Naidu G, Misra D, Pinto B, Adarsh M, Jha S, et al.
Autoimmun Rev
. 2024 Sep;
23(11):103647.
PMID: 39349267
Background: The ACR in 2021 and the EULAR in 2022 published recommendations for management of ANCA-associated vasculitis. Given the differences in the demographic, clinical profiles, and the socio-economic realities between...
5.
6.
Tiwana R, Kamal A, Singh D, Misra D, Salim A, Usman F, et al.
Mediterr J Rheumatol
. 2024 Aug;
35(2):272-282.
PMID: 39211024
Background: The cardiovascular disease (CVD) risk is elevated by 1.5 times among South Asians with rheumatological conditions like rheumatoid arthritis (RA) in the UK. However, there is a dearth of...
7.
Gollarahalli Patel A, Ahmed S, Parida J, Pattanaik S, Gupta L, Aggarwal A, et al.
Rheumatol Int
. 2024 Aug;
44(11):2505-2515.
PMID: 39180530
To look for the spectrum of infections and the factors predisposing to infection in patients with systemic sclerosis (SSc). In this retrospective study, demographic, clinical features, details of infections, immunosuppressive...
8.
Karpouzas G, Ormseth S, van Riel P, Gonzalez-Gay M, Corrales A, Rantapaa-Dahlqvist S, et al.
RMD Open
. 2024 Jul;
10(3).
PMID: 39043615
Objectives: Chronic inflammation promotes cardiovascular risk in rheumatoid arthritis (RA). Biological disease-modifying antirheumatic drugs (bDMARDs) improve disease activity and cardiovascular disease outcomes. We explored whether bDMARDs influence the impact of...
9.
de Souza A, Ooi J, Misra D, Zhong Y, Brown K
Front Immunol
. 2024 Jun;
15:1432069.
PMID: 38887287
No abstract available.
10.
Bolla E, Semb A, Kerola A, Ikdahl E, Petri M, Pons-Estel G, et al.
Lancet Rheumatol
. 2024 Jun;
6(7):e447-e459.
PMID: 38878780
Background: Systemic lupus erythematosus (SLE) is characterised by increased cardiovascular morbidity and mortality risk. We aimed to examine the prevalence of traditional cardiovascular risk factors and their control in an...